SH3YL1

SH3YL1 is a SYLF- and SH3-domain-containing scaffold protein that activates NADPH oxidase Nox4 by forming a ternary complex with Nox4 and p22phox, driving H2O2 production and pro-inflammatory signaling in renal epithelial cells and podocytes; SH3YL1 knockout mice are protected from LPS-induced acute kidney injury and streptozotocin-induced diabetic nephropathy (PMID:33086058, PMID:38318360). SH3YL1 also promotes cancer cell migration through its phosphoinositide-binding domain, which mediates interaction with the proline-rich region of Dock4 to stimulate Dock4-dependent Rac1 activation (PMID:24508479). Additionally, SH3YL1 functions as an androgen receptor coregulator by binding the AR N-terminal polyproline domain, supporting androgen-dependent transcription and prostate cancer cell proliferation (PMID:26305679).

1. 2000 Medium

   Identification of SH3YL1 as a novel SH3-domain protein with hair-follicle-restricted expression established the gene's existence and tissue context but left its molecular function unknown.

   Evidence Differential cDNA library screening, northern blot, and in situ hybridization in mouse hair follicles

   PMID:10771491

   Open questions at the time

   • No biochemical activity or binding partners identified
   • Function of the SH3 domain not tested
   • Expression in non-skin tissues not characterized
2. 2014 Medium

   Demonstration that SH3YL1 binds phosphoinositides and the Dock4 proline-rich region to activate Rac1 revealed a first mechanistic role as a signaling scaffold promoting cell migration.

   Evidence Co-IP, pulldown with domain mutants, Rac1 activation assay, siRNA knockdown with migration assay in MDA-MB-231 breast cancer cells

   PMID:24508479

   Open questions at the time

   • No structural detail of the SH3YL1–Dock4 interface
   • Phosphoinositide specificity and membrane recruitment mechanism not resolved
   • In vivo relevance for migration or metastasis not tested
3. 2015 Medium

   Identification of SH3YL1 as an androgen receptor coregulator expanded its functional repertoire to nuclear transcriptional control, but the interaction was detected by phage display and a single Co-IP direction.

   Evidence T7 phage display, Co-IP, siRNA knockdown with proliferation and migration assays in prostate cancer cells

   PMID:26305679

   Open questions at the time

   • Interaction not confirmed by reciprocal Co-IP or reconstitution with purified proteins
   • Genome-wide AR target gene dependency on SH3YL1 not mapped
   • Whether SH3YL1 enters the nucleus or acts at the cytoplasm–nucleus interface not determined
4. 2020 High

   Discovery that SH3YL1 forms a ternary complex with Nox4 and p22phox to drive H2O2 production established SH3YL1 as a cytosolic activator of NADPH oxidase, linking it to inflammatory kidney injury in vivo.

   Evidence Reciprocal Co-IP, domain deletion/mutation analysis, H2O2 measurement, SH3YL1 knockout mouse with LPS-induced AKI model and histology

   PMID:33086058

   Open questions at the time

   • Stoichiometry and structure of the ternary complex not determined
   • Mechanism by which LPS triggers p22phox–SH3YL1 interaction not identified
   • Whether SH3YL1 activates other Nox family members untested
5. 2024 High

   Podocyte-specific conditional knockout confirmed cell-type-autonomous SH3YL1–Nox4 function in diabetic nephropathy, with corroborating elevation of SH3YL1 protein in patient biopsies, extending the Nox4-activator role to chronic kidney disease.

   Evidence Podocyte-specific (Nphs2-Cre) and global SH3YL1 KO mice in STZ diabetes model, patient biopsy immunohistochemistry, oxidative stress and fibrosis assays

   PMID:38318360

   Open questions at the time

   • Whether pharmacological disruption of SH3YL1–Nox4 is therapeutically feasible not tested
   • Post-translational regulation of SH3YL1 protein levels in disease not characterized
   • Relative contributions of the Dock4/Rac1 versus Nox4 axes in kidney pathology not dissected

• It remains unknown how SH3YL1's distinct scaffolding functions — Nox4 activation, Dock4/Rac1-mediated migration, and AR coregulation — are coordinated or segregated across cell types, and no structural model of any SH3YL1-containing complex exists.
• No crystal or cryo-EM structure of SH3YL1 or its complexes
• No systematic interactome or unbiased proteomics for SH3YL1
• Functional integration of its phosphoinositide-binding, SH3, and SYLF domains across signaling contexts undefined